Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when GeneDx Holdings Corp. publishes a filing, an earnings call transcript or a press release.

Get WGS alerts

About Eric Schadt

Eric Schadt is recorded as Board Member at GeneDx Holdings Corp. (WGS) since May 2, 2022 and CEO at GeneDx Holdings Corp. (WGS) since July 22, 2021. The proxy statement of GeneDx Holdings Corp. reports total compensation of $3,161,612 for Eric Schadt in fiscal 2022, including a base salary of $430,962. Disclosed compensation is on record for 2 fiscal years. Eric Schadt has spoken on 2 earnings calls across 1 company, most recently for GeneDx Holdings Corp. on March 14, 2022. GeneDx Holdings Corp. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at GeneDx Holdings Corp. includes Katherine Stueland (CEO and Board Member), Kevin Feeley (CFO), Richard Miao (CFO) and 7 others.

Eric Schadt on recent calls

“And thank you, everyone, for joining us on our fourth quarter and full year 2021 financial results conference call. I will begin with an overview of our performance, including the recent drivers of our success and future drivers of growth before passing the call to Isaac for a financial update.”
CEO, GeneDx Holdings Corp. Q4 FY2021 Earnings Call ·
“And thanks everyone for joining us this afternoon. We are pleased to be here with you today to discuss our third quarter results and progress against our long-term strategic goals.”
CEO, GeneDx Holdings Corp. Q3 FY2021 Earnings Call ·

Affiliation history

Company network

Leadership on record at GeneDx Holdings Corp.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2022 GeneDx Holdings Corp. (WGS) $430,962 $3,161,612
2021 GeneDx Holdings Corp. (WGS) $650,000 $15,770,836

Recent activity